PCR and NGS-Based Molecular Diagnostics Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: P272895C1EF9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of PCR and NGS-Based Molecular Diagnostics in Global, including the following market information:

Global PCR and NGS-Based Molecular Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global PCR and NGS-Based Molecular Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biomarker Discovery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of PCR and NGS-Based Molecular Diagnostics include Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, Bioo Scientific, Agilent, Pillar Biosciences and LC-Bio Technologies (Hangzhou) CO. LTD., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PCR and NGS-Based Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global PCR and NGS-Based Molecular Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global PCR and NGS-Based Molecular Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Biomarker Discovery
• Blood Sample Testig
• Others

Global PCR and NGS-Based Molecular Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global PCR and NGS-Based Molecular Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Academics/Research Institutions
• Others

Global PCR and NGS-Based Molecular Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global PCR and NGS-Based Molecular Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies PCR and NGS-Based Molecular Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies PCR and NGS-Based Molecular Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermofisher
• Illumine
• Paragon Genomics
• Roche
• Qiagen
• Bioo Scientific
• Agilent
• Pillar Biosciences
• LC-Bio Technologies (Hangzhou) CO. LTD.
• iGen Technologies
• Burning Rock

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 PCR and NGS-Based Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global PCR and NGS-Based Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PCR AND NGS-BASED MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size: 2021 VS 2028
2.2 Global PCR and NGS-Based Molecular Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top PCR and NGS-Based Molecular Diagnostics Players in Global Market
3.2 Top Global PCR and NGS-Based Molecular Diagnostics Companies Ranked by Revenue
3.3 Global PCR and NGS-Based Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 PCR and NGS-Based Molecular Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies PCR and NGS-Based Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 PCR and NGS-Based Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 PCR and NGS-Based Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 PCR and NGS-Based Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global PCR and NGS-Based Molecular Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Biomarker Discovery
  4.1.3 Blood Sample Testig
  4.1.4 Others
4.2 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global PCR and NGS-Based Molecular Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Academics/Research Institutions
  5.1.4 Others
5.2 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global PCR and NGS-Based Molecular Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2028
  6.3.2 US PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.3.3 Canada PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.3.4 Mexico PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2028
  6.4.2 Germany PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.4.3 France PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.4.4 U.K. PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.4.5 Italy PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.4.6 Russia PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.4.8 Benelux PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2028
  6.5.2 China PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.5.3 Japan PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.5.4 South Korea PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.5.6 India PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2028
  6.6.2 Brazil PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.6.3 Argentina PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2028
  6.7.2 Turkey PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.7.3 Israel PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028
  6.7.5 UAE PCR and NGS-Based Molecular Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermofisher
  7.1.1 Thermofisher Corporate Summary
  7.1.2 Thermofisher Business Overview
  7.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.1.4 Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Thermofisher Key News
7.2 Illumine
  7.2.1 Illumine Corporate Summary
  7.2.2 Illumine Business Overview
  7.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.2.4 Illumine PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Illumine Key News
7.3 Paragon Genomics
  7.3.1 Paragon Genomics Corporate Summary
  7.3.2 Paragon Genomics Business Overview
  7.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.3.4 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Paragon Genomics Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.4.4 Roche PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Qiagen
  7.5.1 Qiagen Corporate Summary
  7.5.2 Qiagen Business Overview
  7.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.5.4 Qiagen PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Qiagen Key News
7.6 Bioo Scientific
  7.6.1 Bioo Scientific Corporate Summary
  7.6.2 Bioo Scientific Business Overview
  7.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.6.4 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Bioo Scientific Key News
7.7 Agilent
  7.7.1 Agilent Corporate Summary
  7.7.2 Agilent Business Overview
  7.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.7.4 Agilent PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Agilent Key News
7.8 Pillar Biosciences
  7.8.1 Pillar Biosciences Corporate Summary
  7.8.2 Pillar Biosciences Business Overview
  7.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.8.4 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Pillar Biosciences Key News
7.9 LC-Bio Technologies (Hangzhou) CO. LTD.
  7.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Corporate Summary
  7.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
  7.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Key News
7.10 iGen Technologies
  7.10.1 iGen Technologies Corporate Summary
  7.10.2 iGen Technologies Business Overview
  7.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.10.4 iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 iGen Technologies Key News
7.11 Burning Rock
  7.11.1 Burning Rock Corporate Summary
  7.11.2 Burning Rock Business Overview
  7.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Major Product Offerings
  7.11.4 Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.11.5 Burning Rock Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. PCR and NGS-Based Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. PCR and NGS-Based Molecular Diagnostics Market Drivers in Global Market
Table 3. PCR and NGS-Based Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of PCR and NGS-Based Molecular Diagnostics in Global Market
Table 5. Top PCR and NGS-Based Molecular Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global PCR and NGS-Based Molecular Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies PCR and NGS-Based Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 PCR and NGS-Based Molecular Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PCR and NGS-Based Molecular Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Thermofisher Corporate Summary
Table 31. Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 32. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Illumine Corporate Summary
Table 34. Illumine PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 35. Illumine PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Paragon Genomics Corporate Summary
Table 37. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 38. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 41. Roche PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Qiagen Corporate Summary
Table 43. Qiagen PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 44. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Bioo Scientific Corporate Summary
Table 46. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 47. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Agilent Corporate Summary
Table 49. Agilent PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 50. Agilent PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Pillar Biosciences Corporate Summary
Table 52. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 53. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. LC-Bio Technologies (Hangzhou) CO. LTD. Corporate Summary
Table 55. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 56. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. iGen Technologies Corporate Summary
Table 58. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 59. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Burning Rock Corporate Summary
Table 61. Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 62. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. PCR and NGS-Based Molecular Diagnostics Segment by Type in 2021
Figure 2. PCR and NGS-Based Molecular Diagnostics Segment by Application in 2021
Figure 3. Global PCR and NGS-Based Molecular Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PCR and NGS-Based Molecular Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2021
Figure 8. By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 12. US PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 24. China PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Illumine PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Agilent PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)